The Quarterly Research Grant from Cure Parkinson’s funds preclinical and clinical research projects seeking to slow, stop or reverse Parkinson’s disease, prioritising work with a realistic path to clinical testing within five years and supporting disease-modifying research rather than symptomatic relief. The funding remit excludes research directed at symptomatic relief and centres on disease modification
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: